Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Moderna Inc (MRNA)

  • Event
  • Aug. 03, 2022, 05:00 UTC
  • 164
  • 0 comments

Moderna - Corporate Presentation

Comment Full text

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 03, 2022, 04:01 UTC
  • 99
  • 0 comments

Castle Biosciences - Canaccord Genuity 42nd Annual Growth Conference

Comment Full text

United Therapeutics Corporation (UTHR)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 22
  • 1 comments

(47% Neutral) United Therapeutics Corporation (UTHR) Reports 44% Profit Decline for 2022-06-30

Comment Full text

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 23
  • 1 comments

(28% Negative) SURFACE ONCOLOGY, INC. (SURF) Reports 82% Loss Increase for 2022-06-30

Comment Full text

Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 14
  • 1 comments

(19% Negative) HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY (HZNP) Reports 87% Profit Decline for 2022-06-30

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 12
  • 1 comments

(71% Positive) REGENERON PHARMACEUTICALS, INC. (REGN) Reports 131% Profit Growth for 2022-06-30

Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 14
  • 1 comments

(28% Negative) Aclaris Therapeutics, Inc. (ACRS) Reports Net Loss for 2022-06-30

Comment Full text

Veracyte Inc (VCYT)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 14
  • 1 comments

(28% Negative) VERACYTE, INC. (VCYT) Reports 112% Loss Increase for 2022-06-30

Comment Full text

Morphic Therapeutic (MORF)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 16
  • 1 comments

(28% Negative) MORPHIC HOLDING, INC. (MORF) Reports 957% Loss Increase for 2022-06-30

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 13
  • 1 comments

(75% Positive) Seres Therapeutics, Inc. (MCRB) Reports 31% Loss Reduction for 2022-06-30

Comment Full text
  • Previous
  • 241
  • 242
  • 243
  • 244
  • 245
  • Next

Search

News categories

  • Technical Exchange News(11463)
  • Event(3265)
  • SEC News(213132)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136983)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin